Life Science Reit reduces dividend payment due to economic challenges delaying rollout

Life Science Reit (LABS) has announced that it will halve dividends for 2023, reducing the second payment of the year from 3p to 1p per share. Despite reporting strong progress in its annual results for the year ending on 31 December, LABS faced several challenges, including economic uncertainty, occupiers delaying rental decisions and high interest rates.

The company stated that it had no choice but to make a difficult decision to rebase the dividend in order to ensure it was covered by earnings and could grow sustainably from this level. By cutting dividends, LABS aims to have additional financial flexibility to deliver on its strategy effectively.

By Samantha Johnson

As a content writer at, I craft engaging and informative articles that aim to captivate readers and provide them with valuable insights. With a background in journalism and a passion for storytelling, I thoroughly enjoy delving into diverse topics, conducting research, and producing compelling content that resonates with our audience. From breaking news pieces to in-depth features, I strive to deliver content that is both accurate and engaging, constantly seeking to bring fresh perspectives to our readers. Collaborating with a talented team of editors and journalists, I am committed to maintaining the high standards of journalism upheld by our publication.

Leave a Reply